These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33910947)

  • 1. Potential clinical and economic impact of optimised maintenance therapy on discharged patients with COPD after hospitalisation for an exacerbation in China.
    Salem A; Zhong H; Ramos M; Lamotte M; Hu H
    BMJ Open; 2021 Apr; 11(4):e043664. PubMed ID: 33910947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exacerbation in patients with stable COPD in China: analysis of a prospective, 52-week, nationwide, observational cohort study (REAL).
    Yang T; Cai B; Cao B; Kang J; Wen F; Chen Y; Jian W; Wang C
    Ther Adv Respir Dis; 2023; 17():17534666231167353. PubMed ID: 37073797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prompt initiation of triple therapy following hospitalization for a chronic obstructive pulmonary disease exacerbation in the United States: An analysis of the PRIMUS study.
    Evans KA; Pollack M; Portillo E; Strange C; Touchette DR; Staresinic A; Patel S; Tkacz J; Feigler N
    J Manag Care Spec Pharm; 2022 Dec; 28(12):1366-1377. PubMed ID: 36427341
    [No Abstract]   [Full Text] [Related]  

  • 4. Cost-consequence analysis of COPD treatment according to NICE and GOLD recommendations compared with current clinical practice in the UK.
    Wright A; Vioix H; de Silva S; Langham S; Cook J; Capstick T; Quint JK
    BMJ Open; 2022 Jun; 12(6):e059158. PubMed ID: 36691251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT.
    Devereux G; Cotton S; Fielding S; McMeekin N; Barnes PJ; Briggs A; Burns G; Chaudhuri R; Chrystyn H; Davies L; Soyza A; Gompertz S; Haughney J; Innes K; Kaniewska J; Lee A; Morice A; Norrie J; Sullivan A; Wilson A; Price D
    Health Technol Assess; 2019 Jul; 23(37):1-146. PubMed ID: 31343402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of the Aerobika* oscillating positive expiratory pressure device in the management of COPD exacerbations.
    Khoudigian-Sinani S; Kowal S; Suggett JA; Coppolo DP
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3065-3073. PubMed ID: 29089755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic Impact of Reducing Inappropriate Inhaled Corticosteroids Use in Patients With Chronic Obstructive Pulmonary Disease: ISPOR's Guidance on Budget Impact in Practice.
    Fens T; van der Pol S; Kocks JWH; Postma MJ; van Boven JFM
    Value Health; 2019 Oct; 22(10):1092-1101. PubMed ID: 31563251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of compliance with GOLD treatment recommendations on COPD health care resource utilization, cost, and exacerbations among patients with COPD on maintenance therapy.
    Palli SR; Zhou S; Shaikh A; Willey VJ
    J Manag Care Spec Pharm; 2021 May; 27(5):625-637. PubMed ID: 33779246
    [No Abstract]   [Full Text] [Related]  

  • 9. Prompt initiation of maintenance treatment following a COPD exacerbation: outcomes in a large insured population.
    Coutinho AD; Lokhandwala T; Boggs RL; Dalal AA; Landsman-Blumberg PB; Priest J; Stempel DA
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1223-31. PubMed ID: 27354781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-management interventions including action plans for exacerbations versus usual care in patients with chronic obstructive pulmonary disease.
    Lenferink A; Brusse-Keizer M; van der Valk PD; Frith PA; Zwerink M; Monninkhof EM; van der Palen J; Effing TW
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD011682. PubMed ID: 28777450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic impact of delaying initiation with multiple-inhaler maintenance triple therapy in Spanish patients with chronic obstructive pulmonary disease.
    Sicras Mainar A; Huerta A; Navarro Artieda R; Monsó E; Landis SH; Ismaila AS
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2121-2129. PubMed ID: 31571848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergency Hospital Care for Exacerbation of COPD: Is Inhaled Maintenance Therapy Modified?
    Pomares X; Montón C; Baré M; Pont M; Estirado C; Gea J; Quintana JM; Vidal S; Santiago A;
    COPD; 2016; 13(1):11-8. PubMed ID: 26417965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Healthcare costs with tiotropium plus usual care versus usual care alone following 1 year of treatment in patients with chronic obstructive pulmonary disorder (COPD).
    Friedman M; Menjoge SS; Anton SF; Kesten S
    Pharmacoeconomics; 2004; 22(11):741-9. PubMed ID: 15250751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supported self-management for patients with moderate to severe chronic obstructive pulmonary disease (COPD): an evidence synthesis and economic analysis.
    Jordan RE; Majothi S; Heneghan NR; Blissett DB; Riley RD; Sitch AJ; Price MJ; Bates EJ; Turner AM; Bayliss S; Moore D; Singh S; Adab P; Fitzmaurice DA; Jowett S; Jolly K
    Health Technol Assess; 2015 May; 19(36):1-516. PubMed ID: 25980984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costs of chronic obstructive pulmonary disease in urban areas of China: a cross-sectional study in four cities.
    Chen X; Wang N; Chen Y; Xiao T; Fu C; Xu B
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2625-2632. PubMed ID: 27799761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The burden of chronic obstructive pulmonary disease associated with maintenance monotherapy in the UK.
    Edwards SC; Fairbrother SE; Scowcroft A; Chiu G; Ternouth A; Lipworth BJ
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2851-2858. PubMed ID: 27920512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Order Set to Improve the Care of Patients Hospitalized for an Exacerbation of Chronic Obstructive Pulmonary Disease.
    Brown KE; Johnson KJ; DeRonne BM; Parenti CM; Rice KL
    Ann Am Thorac Soc; 2016 Jun; 13(6):811-5. PubMed ID: 27058777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the healthcare resource use associated with inappropriate prescribing of inhaled corticosteroids for people with chronic obstructive pulmonary disease (COPD) in GOLD groups A or B: an observational study using the Clinical Practice Research Datalink (CPRD).
    Chalmers JD; Poole C; Webster S; Tebboth A; Dickinson S; Gayle A
    Respir Res; 2018 Apr; 19(1):63. PubMed ID: 29642882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rising Costs of COPD and the Potential for Maintenance Therapy to Slow the Trend.
    Blanchette CM; Gross NJ; Altman P
    Am Health Drug Benefits; 2014 Apr; 7(2):98-106. PubMed ID: 24991394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment patterns of chronic obstructive pulmonary disease in employed adults in the United States.
    Diette GB; Dalal AA; D'Souza AO; Lunacsek OE; Nagar SP
    Int J Chron Obstruct Pulmon Dis; 2015; 10():415-22. PubMed ID: 25759574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.